HomeLatest NewsCovid-19NIH, FDA Act to Increase Access to Over-the-Counter COVID-19 Tests

NIH, FDA Act to Increase Access to Over-the-Counter COVID-19 Tests

The National Institutes of Health (NIH) will use $70 million from the American Rescue Plan Act for a program to speed development of accurate and reliable over-the-counter tests for COVID-19, the Department of Health and Human Services announced. The NIH Independent Test Assessment Program will work with the Food and Drug Administration (FDA), manufacturers and experts to speed emergency use authorizations for new tests that can increase production quickly, officials said.

In related news, the FDA recommended labeling updates to facilitate over-the-counter single-use testing for symptomatic individuals for tests currently authorized only for serial testing. It also granted an emergency use authorization to Celltrion Diatrust for an over-the-counter rapid antigen test, and reauthorized the Quidel QuickVue at-home test to add over-the-counter single-use testing for symptomatic adults and children.

Stay Connected

Unified Voice Newsletter

Events This Month


30may11:00 am12:00 pmWorkplace Violence Prevention and Response StrategiesSDAHO Webinar


31may12:00 pm1:00 pmResidents with a Schizophrenia Diagnosis: Now What?SDAHO Webinar

31mayAll Day01junMission Possible | Reducing the Impact of Substance Abuse + Mental Illness

By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact